EXACT Therapeutics AS (OSL:EXTX)

Market Cap	54.72M -72.1%
Revenue (ttm)	59.00K
Net Income	-86.97M
EPS	-1.37
Shares Out	63.26M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	109,741
Open	0.7100
Previous Close	0.7100
Day's Range	0.7100 - 0.9250
52-Week Range	0.6000 - 3.0200
Beta	0.08
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 3, 2026

About EXACT Therapeutics AS

EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a novel ultrasound-mediated technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT) in Norway. The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various applications, including oncology, neurological conditions, and gene therapy. The company’s ACT platform is under Phase 2 clinical trial for the treatment of pancreatic diseas...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2012
• Employees: 11
• Stock Exchange: Oslo Børs
• Ticker Symbol: EXTX